Annual report
4888.TEDINET S100W6ZM
Period2024-04-01 → 2025-03-31
Filed2025-06-26
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥961m | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥269m | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥229m | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥100m | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥206m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥90m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | −¥760m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | −¥138m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥760m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥776m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥764m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥656m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥138m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥761m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | −¥141m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥764m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥779m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥768m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥659m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥3.8bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥4.3bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.7bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.0bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.2bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.4bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.2bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.4bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.8bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥3.1bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥231m | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.1bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥3.2bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2024-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2023-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.2bn | at 2022-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥838m | at 2021-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥140m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥877m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥828m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥773m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥288m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥9m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥30m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥351m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥23m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥721m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥228m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥292m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.8bn | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥332m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-4.22 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-24.66 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-26.97 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-27.34 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-32.9 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥94.26 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥75.9 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥91.51 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥107.39 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥11.46 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 59.2% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.0% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.3% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.3% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 11.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 34,034,100 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 31,225,500 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 29,966,300 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 28,676,100 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 20,137,400 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 43 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 44 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 46 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 43 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 43 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 844
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in financing activities | Prior1YearDuration_NonConsolidatedMember | 228353000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration_NonConsolidatedMember | 721253000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration_NonConsolidatedMember | -657493000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration_NonConsolidatedMember | 1149238000 | JPY |
| Cash and cash equivalents | Prior2YearInstant_NonConsolidatedMember | 2669727000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 2012233000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 2012233000 | JPY |
| Cash and cash equivalents | CurrentYearInstant_NonConsolidatedMember | 3161471000 | JPY |
| Write downs of inventories | Prior1YearDuration_NonConsolidatedMember | 19502000 | JPY |
| Write downs of inventories | CurrentYearDuration_NonConsolidatedMember | 28000 | JPY |
| Salaries and allowances sga | Prior1YearDuration_NonConsolidatedMember | 184867000 | JPY |
| Salaries and allowances sga | CurrentYearDuration_NonConsolidatedMember | 182687000 | JPY |
| Provision for bonuses ga | Prior1YearDuration_NonConsolidatedMember | 365000 | JPY |
| Provision for bonuses ga | CurrentYearDuration_NonConsolidatedMember | 255000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration_NonConsolidatedMember | 5397000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration_NonConsolidatedMember | 4751000 | JPY |
| Provision for share based payments sga | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Provision for share based payments sga | CurrentYearDuration_NonConsolidatedMember | 3447000 | JPY |
| Depreciation sga | Prior1YearDuration_NonConsolidatedMember | 13613000 | JPY |
| Depreciation sga | CurrentYearDuration_NonConsolidatedMember | 17025000 | JPY |
| Research and development expenses sga | Prior1YearDuration_NonConsolidatedMember | 393555000 | JPY |
| Research and development expenses sga | CurrentYearDuration_NonConsolidatedMember | 328407000 | JPY |
| Business consignment expenses sga | Prior1YearDuration_NonConsolidatedMember | 85086000 | JPY |
| Business consignment expenses sga | CurrentYearDuration_NonConsolidatedMember | 117839000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | Prior1YearDuration_NonConsolidatedMember | 393555000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | CurrentYearDuration_NonConsolidatedMember | 328407000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-06-26 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第18期（自 2024年４月１日 至 2025年３月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ステラファーマ株式会社 | |
| Company name in english cover page | FilingDateInstant | STELLA PHARMA CORPORATION | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 上原 幸樹 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪市中央区高麗橋三丁目２番７号 ＯＲＩＸ高麗橋ビル | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)(06)4707-1516（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)管理本部長 伊神 尚 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪市中央区高麗橋三丁目２番７号 ＯＲＩＸ高麗橋ビル | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)(06)4707-1516（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)管理本部長 伊神 尚 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E35496 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 48880 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ステラファーマ株式会社 | |
| Filer name in english | FilingDateInstant | STELLA PHARMA CORPORATION | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |